SC1011

DRUG3 trials

Sponsors

Guangzhou JOYO Pharma Co., Ltd

Conditions

Diopathic Pulmonary FibrosisIdiopathic Pulmonary FibrosisPulmonary Fibrosis

Phase 1

Safety, Tolerability and Pharmacokinetic Study of SC1011 in Healthy Subjects

CompletedNCT06135363

Guangzhou JOYO Pharma Co., LtdIdiopathic Pulmonary Fibrosis

Start: 2022-08-11End: 2023-01-14Updated: 2023-11-18

The Safety, Tolerability, and Pharmacokinetic Study of SC1011 in Healthy Subjects.

CompletedNCT06160440

Guangzhou JOYO Pharma Co., LtdDiopathic Pulmonary Fibrosis, Pulmonary Fibrosis

Start: 2021-06-03End: 2022-02-23Updated: 2024-11-19

Phase 2

SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)

RecruitingNCT06125327

Guangzhou JOYO Pharma Co., LtdIdiopathic Pulmonary Fibrosis

Start: 2023-06-06End: 2027-12-31Target: 210Updated: 2024-11-19